temsirolimus

Ligand id: 5892

Name: temsirolimus

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: temsirolimus

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 17
Hydrogen bond donors 4
Rotatable bonds 11
Topological polar surface area 241.96
Molecular weight 1029.6
XLogP 3.54
No. Lipinski's rules broken 2

Molecular properties generated using the CDK

Classification
Compound class Synthetic organic
Approved drug? Yes (FDA & EMA (2007))
International Nonproprietary Names
INN number INN
8212 temsirolimus
Synonyms
CCI-779 | Torisel®
Database Links
CAS Registry No. 162635-04-3 (source: SciFinder)
ChEMBL Ligand CHEMBL1201182
DrugBank Ligand DB06287
GtoPdb PubChem SID 178102515
PubChem CID 6918289
Search Google for chemical match using the InChIKey CBPNZQVSJQDFBE-FUXHJELOSA-N
Search Google for chemicals with the same backbone CBPNZQVSJQDFBE
Search PubMed clinical trials temsirolimus
Search PubMed titles temsirolimus
Search PubMed titles/abstracts temsirolimus
Search UniChem for chemical match using the InChIKey CBPNZQVSJQDFBE-FUXHJELOSA-N
Search UniChem for chemicals with the same backbone CBPNZQVSJQDFBE
Wikipedia Temsirolimus
Comments
Temsirolimus is a Type-3 kinase inhibitor and was first approved by the FDA in 2007. There is some ambiguity in the literature surrounding the exact stereochemistry of temsirolimus. Other common representations are CID 23724530, CID 24847874 and CID 9876533. Our representation and the PubChem and ChEMBL links in the table above show a structure identical to that contained in the INN record for this drug.